1. Home
  2. OXSQ vs SERA Comparison

OXSQ vs SERA Comparison

Compare OXSQ & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxford Square Capital Corp.

OXSQ

Oxford Square Capital Corp.

HOLD

Current Price

$1.78

Market Cap

151.1M

Sector

Finance

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$3.53

Market Cap

130.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXSQ
SERA
Founded
2003
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.1M
130.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
OXSQ
SERA
Price
$1.78
$3.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
788.1K
51.5K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
23.46%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,142,565.00
$95,000.00
Revenue This Year
N/A
$19.22
Revenue Next Year
$2.27
$400.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.06
52 Week Low
$1.56
$1.37
52 Week High
$2.87
$9.13

Technical Indicators

Market Signals
Indicator
OXSQ
SERA
Relative Strength Index (RSI) 39.22 58.09
Support Level $1.82 $3.20
Resistance Level $1.87 $3.72
Average True Range (ATR) 0.04 0.28
MACD -0.00 0.04
Stochastic Oscillator 16.83 76.93

Price Performance

Historical Comparison
OXSQ
SERA

About OXSQ Oxford Square Capital Corp.

Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: